HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Failures During Heparin Crisis Drive Congress’ Stronger Drug Safety Push

This article was originally published in The Tan Sheet

Executive Summary

FDA's role in the handling of contaminated-heparin crisis is illustrative of "the best and the worst" of its performance under the administration, said David Nelson, senior investigator for the House Energy and Commerce Committee

You may also be interested in...



Globalization Act’s Drug Safety Provisions Look Harmful For Industry

The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys

Salmonella Problem Stirs Food Safety Bills, Hearing From Energy & Commerce

At an upcoming hearing, House Energy and Commerce Committee leaders will question executives from labs that tested ingredients at the peanut processing facility linked to widespread recalls due to salmonella contamination

Energy And Commerce Changes, But Stupak Keeps Subcommittee Chair

A frequent critic of FDA and the drug industry remains in the House Energy and Commerce Committee leadership, but the drug and dietary supplement industries are preparing to work with different staff at the crucial committee

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137591

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel